CN107793429A - A kind of preparation method of qinghaosu - Google Patents

A kind of preparation method of qinghaosu Download PDF

Info

Publication number
CN107793429A
CN107793429A CN201610767931.3A CN201610767931A CN107793429A CN 107793429 A CN107793429 A CN 107793429A CN 201610767931 A CN201610767931 A CN 201610767931A CN 107793429 A CN107793429 A CN 107793429A
Authority
CN
China
Prior art keywords
qinghaosu
acid
preparation
dihydroartemisinic acid
dihydroartemisinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610767931.3A
Other languages
Chinese (zh)
Inventor
宋德成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Pacific Pharmaceutical Co Ltd
Original Assignee
Tianjin Pacific Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Pacific Pharmaceutical Co Ltd filed Critical Tianjin Pacific Pharmaceutical Co Ltd
Priority to CN201610767931.3A priority Critical patent/CN107793429A/en
Publication of CN107793429A publication Critical patent/CN107793429A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20Spiro-condensed systems

Abstract

The invention discloses a kind of preparation method of qinghaosu, using Arteannuic acid as initiation material, dihydroartemisinic acid is obtained under hydrogen/metallic catalyst effect, then, dihydroartemisinic acid is in the presence of sodium molybdate by hydrogen peroxide oxidation into peroxidating dihydroartemisinic acid, finally acted under trifluoromethanesulfonic acid copper catalysis with oxygen, you can obtain target product qinghaosu in high yield.Compared with prior art, the invention has the advantages that:Agents useful for same is cheap and easily-available, and synthetic route is short, and reaction selectivity is high, and preparation process is environmentally friendly, and operation and post processing are simple, and total recovery is high, is adapted to industrialized production.

Description

A kind of preparation method of qinghaosu
Technical field
The present invention relates to a kind of preparation method of qinghaosu, belongs to organic drug synthesis field.
Background technology
Qinghaosu (Artemisinin), that is extracted from Chinese medicine artemisia annua has the sesquiterpene lactone anti-malarial of peroxy-radical Class medicine is Chinese first found by internationally recognized natural drug.The antimalarial mechanism of qinghaosu and other antimalarials are not Together, its main function is pellicle-mitochondrial function by disturbing plasmodium, and non-interference folic acid metabolism, so as to cause worm Body structure is all disintegrated.In addition, using qinghaosu as raw material, can also synthesize its a variety of derivative, as dihydroartemisinine, Artemether, Artesunate etc..These artemisinin-based drug toxicity are low, resist cruel property strong, are approved as treating encephalic malaria in world wide by WTO With the choice drug of pernicious malaria.
Patent US4992561 introduces peroxide bridge using dihydroartemisinic acid as raw material using photochemical method.Due to photochemical The limitation of itself is learned, it is such as cumbersome, it should not mass produce, therefore industrialized production difficult to realize.Document (Tetrahedron, 1986,42,819-828) report with (R)-(+)-vanillic aldehyde be raw material come the method for synthetic artemisinin, Grown yet with synthetic route, total recovery is low, and Atom economy is poor.In addition peroxide is introduced and using photochemical method Key, it is difficult to realize industrialized production.Other are such as Mitchell A.Avery (J.Am.Chem.Soc., 1992.114.974-979) Report is Material synthesis qinghaosu using pulegone, and its synthetic route is longer, yield is low.Simultaneously peroxide is introduced using ozone Key, operating difficulties, security is poor, and industrial prospect is not high.If realize peroxide bridge using traditional chemical synthesis process Introduce, it is not only workable, also it is very likely to test industrialized production.Document (J.Am.Chem.Soc., 1964,86, 3880, J.Am.Chem.Soc., 1968,90,975) it is reported in the presence of certain catalyst, singlet is produced using oxygen Oxygen, and then the introducing of peroxide bridge can also be realized instead of photochemical method.
The content of the invention
The defects of purpose of the present invention is exactly to overcome prior art to exist and a kind of rational technology, simple to operate is provided And the preparation method for the antimalarial class drug artemisinin that cost is cheap and total recovery is high.
The purpose of the present invention can be achieved through the following technical solutions:
A kind of preparation method of qinghaosu, it is characterised in that comprise the following steps:
Step 1), Arteannuic acid is dissolved in organic solvent, acted on by hydrogen/metallic catalyst, reduced and dihydro green grass or young crops is made Artemisic acid;
Step 2), dihydroartemisinic acid in organic solvent, using sodium molybdate as catalyst, hydrogen peroxide as oxidant, Peroxide dihydroartemisinic acid is made in oxidation;
Step 3), peroxide dihydroartemisinic acid are passed through oxygen under copper trifluoromethanesulfcomposite effect, reset and obtain qinghaosu.
Further, in step 1), the metallic catalyst is palladium carbon, Raney Ni, platinum oxide, wherein, metal catalytic Agent dosage is the 0.01-0.1 of Arteannuic acid weight, and Hydrogen Vapor Pressure 1-10bar, reaction temperature is -50 DEG C of room temperature.
Further, the organic solvent selection dichloromethane, chloroform, acetone, methanol, ethanol, propyl alcohol, isopropanol, third One kind or its mixing in ketone, ethyl acetate, tetrahydrofuran, dioxane, acetonitrile, DMF, DMSO.
Further, in step 2), the mole dosage of the sodium molybdate is 1-5 times of Arteannuic acid, hydrogen peroxide mole Dosage is 2-10 times of Arteannuic acid.
Further, in step 2), the oxidation reaction is carried out under the conditions of -10-0 DEG C.
Further, in step 3), the rearrangement reaction is carried out under 0 DEG C-room temperature condition, and copper trifluoromethanesulfcomposite rubs Your dosage is 1-10 times of dihydroartemisinic acid.
The synthetic route of the present invention is as follows:
Beneficial effects of the present invention:Step 1), obtained with accessory substance in qinghaosu extraction process or by fermentation process Arteannuic acid is initiation material, and cost is low, and stereoselectivity is good, and product purity is high, and reaction yield is high, is easy to mass produce;Step Rapid 2) hydrogen peroxide is green as oxidant, and post processing is simple, and reaction condition is gentle, and yield is high, beneficial to industrial metaplasia Production;Step 3), reaction use cheap reagent, and mild condition is simple to operate, and yield is high.On the whole, preparation road of the present invention Line yield is high, and reaction condition is gentle, green, and cost is cheap, is especially suitable for industrialized production.
Embodiment
The invention discloses a kind of preparation method of qinghaosu, those skilled in the art can use for reference present disclosure, suitably Modified technique parameter is realized.It is important to note that all similar replacements and change are for a person skilled in the art It will be apparent that they are considered as being included in the present invention, and related personnel can substantially not depart from present invention, spirit Content described herein is modified or suitably changed with combining with the basis of scope, to realize and using the technology of the present invention.
In the present invention, unless otherwise stated, Science and Technology noun used herein has art technology The implication that personnel are generally understood that.
In order that those skilled in the art more fully understands technical scheme, with reference to specific embodiment pair The present invention is described in further detail.
Embodiment 1:
100g (0.43mol) Arteannuic acid is dissolved in 800mL chloroforms, at ambient temperature, Hydrogen Vapor Pressure 1bar, 1.5g palladium Carbon overnight, diatomite filtering, chloroform, is recovered under reduced pressure solvent, obtains solid product dihydroartemisinic acid as catalyst, reaction 99g (0.42mol), yield 98%.
100g (0.42mol) dihydroartemisinic acid is dissolved in 500mL acetone, using 105g (0.44mol) sodium molybdates as urging Agent, under the conditions of -10 DEG C, 30% hydrogen peroxide is slowly added dropwise as oxidant 150mL (about 1.32mol), reacts 24 hours, mistake Filter, 200mL dichloromethane extract three times, organic phase anhydrous sodium sulfate drying.
Above-mentioned reaction solution is taken, is cooled to 0 DEG C, adds 200g (0.55mol) copper trifluoromethanesulfcomposite, is passed through oxygen, monitoring is anti- Process is answered, question response terminates, and filtering, dichloromethane rinses, and solvent is recovered under reduced pressure, gained solid is recrystallized through methanol-water, produced Qinghaosu 75g (0.27mol), yield 63%.
Embodiment 2:
100g (0.43mol) Arteannuic acid is dissolved in 1000mL tetrahydrofurans, at ambient temperature, Hydrogen Vapor Pressure 2bar, 5.5g Raney Nis overnight, diatomite filtering, ethyl acetate washing, are recovered under reduced pressure solvent, obtain solid product as catalyst, reaction Dihydroartemisinic acid 96g (0.41mol), yield 95%.
100g (0.42mol) dihydroartemisinic acid is dissolved in 500mL isopropanols, using 105g (0.44mol) sodium molybdates as Catalyst, under the conditions of -10 DEG C, 30% hydrogen peroxide is slowly added dropwise as oxidant 150mL (about 1.32mol), reacts 24 hours, Filtering, 200mL dichloromethane extract three times, organic phase anhydrous sodium sulfate drying.
Above-mentioned reaction solution is taken, is cooled to 0 DEG C, adds 180g (0.50mol) copper trifluoromethanesulfcomposite, is passed through oxygen, monitoring is anti- Process is answered, question response terminates, and filtering, dichloromethane rinses, and solvent is recovered under reduced pressure, gained solid is recrystallized through methanol-water, produced Qinghaosu 69g (0.24mol), yield 57%.
Embodiment 3:
100g (0.43mol) Arteannuic acid is dissolved in 800mL propyl alcohol, under the conditions of 40 DEG C, Hydrogen Vapor Pressure 2bar, 1.5g palladium Carbon overnight, diatomite filtering, chloroform, is recovered under reduced pressure solvent, obtains solid product dihydroartemisinic acid as catalyst, reaction 98g (0.41mol), yield 96%.
100g (0.42mol) dihydroartemisinic acid is dissolved in 600mL acetonitriles, using 125g (0.52mol) sodium molybdates as urging Agent, under the conditions of 0 DEG C, 30% hydrogen peroxide is slowly added dropwise as oxidant 150mL (about 1.32mol), reacts 24 hours, mistake Filter, 200mL dichloromethane extract three times, organic phase anhydrous sodium sulfate drying.
Take above-mentioned reaction solution, at room temperature, add 200g (0.55mol) copper trifluoromethanesulfcomposite, be passed through oxygen, monitoring react into Journey, question response terminate, and filtering, dichloromethane rinses, and solvent is recovered under reduced pressure, gained solid recrystallizes through methanol-water, produces sweet wormwood Plain 77g (0.27mol), yield 65%.

Claims (6)

1. a kind of preparation method of qinghaosu, it is characterised in that comprise the following steps:
Step 1), Arteannuic acid is dissolved in organic solvent, acted on by hydrogen/metallic catalyst, reduced and dihydroartemisinic acid is made;
Step 2), in organic solvent, using sodium molybdate as catalyst, hydrogen peroxide is as oxidant, oxidation for dihydroartemisinic acid Peroxide dihydroartemisinic acid is made;
Step 3), peroxide dihydroartemisinic acid are passed through oxygen under copper trifluoromethanesulfcomposite effect, reset and obtain qinghaosu.
A kind of 2. preparation method of qinghaosu according to claim 1, it is characterised in that:In step 1), the metal catalytic Agent is palladium carbon, Raney Ni, platinum oxide, wherein, amount of metal catalyst is the 0.01-0.1, Hydrogen Vapor Pressure 1- of Arteannuic acid weight 10bar, reaction temperature are -50 DEG C of room temperature.
A kind of 3. preparation method of qinghaosu according to claim 1, it is characterised in that:The organic solvent selects dichloromethane Alkane, chloroform, acetone, methanol, ethanol, propyl alcohol, isopropanol, acetone, ethyl acetate, tetrahydrofuran, dioxane, acetonitrile, DMF, One kind or its mixing in DMSO.
A kind of 4. preparation method of qinghaosu according to claim 1, it is characterised in that:In step 2), the sodium molybdate Mole dosage is 1-5 times of dihydroartemisinic acid, and hydrogen peroxide mole dosage is 2-10 times of Arteannuic acid.
A kind of 5. preparation method of qinghaosu according to claim 1, it is characterised in that:In step 2), the oxidation reaction Carried out under the conditions of -10-0 DEG C.
A kind of 6. preparation method of qinghaosu according to claim 1, it is characterised in that:In step 3), the rearrangement reaction Carried out under 0 DEG C-room temperature condition, the mole dosage of copper trifluoromethanesulfcomposite is 1-10 times of dihydroartemisinic acid.
CN201610767931.3A 2016-08-30 2016-08-30 A kind of preparation method of qinghaosu Pending CN107793429A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610767931.3A CN107793429A (en) 2016-08-30 2016-08-30 A kind of preparation method of qinghaosu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610767931.3A CN107793429A (en) 2016-08-30 2016-08-30 A kind of preparation method of qinghaosu

Publications (1)

Publication Number Publication Date
CN107793429A true CN107793429A (en) 2018-03-13

Family

ID=61528081

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610767931.3A Pending CN107793429A (en) 2016-08-30 2016-08-30 A kind of preparation method of qinghaosu

Country Status (1)

Country Link
CN (1) CN107793429A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103087074A (en) * 2012-12-14 2013-05-08 湖南科源生物制品有限公司 Method of semi-synthesizing artemisinin
CN103172645A (en) * 2012-06-05 2013-06-26 上海交通大学 High-efficiency synthesis method of artemisinin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103172645A (en) * 2012-06-05 2013-06-26 上海交通大学 High-efficiency synthesis method of artemisinin
CN103087074A (en) * 2012-12-14 2013-05-08 湖南科源生物制品有限公司 Method of semi-synthesizing artemisinin

Similar Documents

Publication Publication Date Title
CN108033922B (en) Preparation method of 3-acyl quinoxalinone derivative
Fattorusso et al. Antimalarials based on the dioxane scaffold of plakortin. A concise synthesis and SAR studies
Kumar et al. Iodine-catalyzed one-pot synthesis and antimalarial activity evaluation of symmetrically and asymmetrically substituted 3, 6-diphenyl [1, 2, 4, 5] tetraoxanes
Atheaya et al. Synthesis, thermal stability, antimalarial activity of symmetrically and asymmetrically substituted tetraoxanes
Yadav et al. Synthesis and evaluation of anti-plasmodial and cytotoxic activities of epoxyazadiradione derivatives
WO2008087666A1 (en) Preparative process for ether derivative of artemisinin
Žmitek et al. Synthesis and antimalarial activities of novel 3, 3, 6, 6-tetraalkyl-1, 2, 4, 5-tetraoxanes
CN107793429A (en) A kind of preparation method of qinghaosu
CN116621810A (en) Process for preparing 2-methyl nicotine
CN105175317B (en) A kind of method for preparing picosulfate sodium
WO2006070862A1 (en) Process for producing carbon-diminished aldose compound
CN107118247B (en) The preparation method of selamectin
Wang et al. Michael acceptor in gambogic acid—Its role and application for potent antitumor agents
Saito et al. Discoveries and syntheses of highly potent antimalarial troponoids
CN105330590B (en) The preparation method of sitafloxacin five-membered ring side chain intermediate
CN115197232A (en) Cyclopropane fused oxygen bridge hexacyclic compound and synthesis method thereof
CN115340481A (en) Method for industrially producing deuterated medical intermediate by adopting immobilized nickel catalysis
CN109796462A (en) A kind of preparation method of irinotecan hydrochloride
CN116983264B (en) Embedding system of dihydrocannabidiol dibenzoate as well as preparation method and application thereof
Nadali et al. Efficient reductive Claisen rearrangement of prop-2'-enyloxyanthraquinones and 2'-chloroprop-2'-enyloxyanthraquinones with iron powder in ionic liquids
CN116983266B (en) Embedding system of dihydrocannabidiol difurancarboxylate and preparation method and application thereof
Gao et al. The first total synthesis of 7-O-β-d-glucopyranosyl-4′-O-α-l-rhamnopyranosyl apigenin via a hexanoyl ester-based protection strategy
CN116983267B (en) Embedding system of dihydrocannabidiol dinitrate and preparation method and application thereof
CN103724304B (en) The preparation method of 5-bromobenzofuran
CN113735873B (en) Method for preparing Artemisinin G

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180313

WD01 Invention patent application deemed withdrawn after publication